mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |